Immune checkpoint inhibitors (ICIs), for example, inhibitors targeting programmed cell death 1 (PDCD1) protein and its ligand protein of PD-L1, have made a significant contribution to tumor immunotherapy [36]. The gene discussed is PDCD1; the disease is neoplasm.